Consider three robust stocks with both a buy rank and potent momentum features for potential investment today, February 8:
Post Holdings, Inc. POST, a consumer-packaged goods holding company, boasts a Zacks Rank #1 and a 9.2% surge in the Zacks Consensus Estimate for its current year earnings over the past 60 days.
Post Holdings, Inc. on the Rise
Post Holdings’ shares have outperformed the S&P 500’s advance by soaring 24% in the last three months and the company possesses an impressive Momentum Score of A.
Post Holdings, Inc. Price
Inhibikase Therapeutics, Inc. IKT, a pharmaceutical company, displays a Zacks Rank #1 and an impressive 16% climb in the Zacks Consensus Estimate for its current year earnings over the past 60 days.
Rise of Inhibikase Therapeutics, Inc.
With an extraordinary 172.1% surge in the last three months compared to the S&P 500, Inhibikase Therapeutics, Inc. also boasts a Momentum Score of A.
Inhibikase Therapeutics, Inc. Price
ACM Research, Inc. ACMR, a semiconductor equipment company, also holds a Zacks Rank #1 and registered a 3.1% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days.
ACM Research, Inc. on the Upward Trajectory
ACM Research’s shares have surged by 23.1% in the last six months compared to the S&P 500 and the company holds a Momentum Score of A.
ACM Research, Inc. Price
Explore the complete list of top-performing stocks here.
Gain a deeper understanding of the Momentum score and its calculation here.
See This Stock Now for Free >>
ACM Research, Inc. (ACMR) : Free Stock Analysis Report
Post Holdings, Inc. (POST) : Free Stock Analysis Report
Inhibikase Therapeutics, Inc. (IKT) : Free Stock Analysis Report
Find this article on Zacks.com by clicking here.
The viewpoints revealed here are those of the author and not necessarily reflect those of Nasdaq, Inc.
